ASSANTO, GIOVANNI MANFREDI

ASSANTO, GIOVANNI MANFREDI  

DIPARTIMENTO DI CHIRURGIA  

Mostra prodotti
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.065 secondi).
Titolo Data di pubblicazione Autore(i) File
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al 2022 Serrao, Alessandra; Assanto, Giovanni Manfredi; Malfona, Francesco; Chavez Orellana, Gabriela; Chistolini, Antonio
A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD 2024 Sorella, Silvia; Assanto, GIOVANNI MANFREDI; Maria D’Elia, Gianna; Annechini, Giorgia; Totaro, Matteo; Celia, Renata; Bruno, Leonardo; Placidi, Fabio; Martelli, Maurizio; DEL GIUDICE, Ilaria
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients? 2023 Pulsoni, A; Assanto, G M; Salvatori, M; Musiu, P; Luise, C; Passucci, M; Lapietra, G; Pappalardo, L; Annechini, G; D'Elia, G M; Martelli, M; Del Giudice, I
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients 2023 Chistolini, A; Serrao, A; Assanto, G M; Genoese, A; Baldacci, E; Ligia, S; Breccia, M; Santoro, C
Asciminib in chronic myeloid leukemia 2022 Assanto, Giovanni Manfredi; Scalzulli, Emilia; Breccia, Massimo
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study 2023 Micozzi, Alessandra; Minotti, Clara; Capria, Saveria; Cartoni, Claudio; Trisolini, Silvia Maria; Assanto, Giovanni Manfredi; Barberi, Walter; Moleti, Maria Luisa; Santilli, Stefania; Martelli, Maurizio; Gentile, Giuseppe
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience (Bone Marrow Transplantation, (2021), 56, 6, (1455-1457), 10.1038/s41409-020-01174-w) 2021 Bruzzese, A.; Assanto, G. M.; Diverio, D.; Quattrocchi, L.; Carmini, D.; La Rocca, U.; De Propris, M. S.; Trisolini, S. M.; Brescini, M.; Galassi, G.; Barberi, W.; Iori, A. P.
Direct oral Anticoagulants (DOACs) in the Onco-Hematologic Patients 2025 Biglietto, M.; Ligia, S.; Lagana, A.; Assanto, G. M.; Gherardini, M.; Baldacci, E.; Santoro, C.; Chistolini, A.
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies 2022 Serrao, Alessandra; Malfona, Francesco; Assanto, Giovanni Manfredi; Orellana, Maria Gabriela Chavez; Santoro, Cristina; Chistolini, Antonio
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome 2023 Ligia, Silvio; Passucci, Mauro; Assanto, GIOVANNI MANFREDI; D'Elia GIanna Maria, ; Annechini, Giorgia; DE PROPRIS, Maria Stefania; Martelli, Maurizio; DEL GIUDICE, Ilaria; Tiacci, Enrico; Pulsoni, Alessandro
Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis 2024 Laganà, Alessandro; Assanto, Giovanni Manfredi; Passucci, Mauro; Santoro, Cristina; Chistolini, Antonio
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment 2022 Di Rocco, Alice; Petrucci, Luigi; Assanto, Giovanni Manfredi; Martelli, Maurizio; Pulsoni, Alessandro
EZH2 gene mutations and copy number variation as prognostic markers in advanced follicular lymphoma 2025 Assanto, GIOVANNI MANFREDI
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care 2022 Assanto, Giovanni Manfredi; Scalzulli, Emilia; Carmosino, Ida; Martelli, Maurizio; Breccia, Massimo
Hematopoietic Stem Cell Transplantation in Myelofibrosis: The Experience of Three University Transplant Centres in Rome 2020 Galassi, Giulia; Chiusolo, Patrizia; Cerretti, Raffaella; Barberi, Walter; Quattrocchi, Luisa; La Rocca, Ursula; Sora, Federica; Rossi, Valentina; Assanto, Giovanni Manfredi; Brescini, Mattia; Ricci, Roberto; Latagliata, Roberto; Breccia, Massimo; Arcese, William; Bacigalupo, Andrea; Sica, Simona; Iori, Anna Paola
High basal maximal standardized uptake value (Suvmax) in follicular lymphoma identifies patients with a low risk of long-term relapse 2021 Assanto, G. M.; Ciotti, G.; Brescini, M.; De Luca, M. L.; Annechini, G.; D'Elia, G. M.; Agrippino, R.; Del Giudice, I.; Martelli, M.; Chiaravalloti, A.; Pulsoni, A.
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study 2023 Assanto, G. M.; Di Rocco, A.; Malfona, F.; Capriata, M.; Del Giudice, I.; Petrucci, L.; Girardi, P.; D'Elia, G. M.; Martelli, M.; Gentile, G.; Micozzi, A.; Pulsoni, A.
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study 2022 Assanto, GIOVANNI MANFREDI; DI ROCCO, Alice; Malfona, Francesco; Capriata, Marcello; DEL GIUDICE, Ilaria; Petrucci, Luigi; Girardi, Paola; Maria D'elia, Gianna; Martelli, Maurizio; Gentile, Giuseppe; Micozzi, Alessandra; Pulsoni, Alessandro
Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study 2024 Passucci, Mauro; Fazio, Francesca; Micozzi, Jacopo; Bafti, Manhaz Shafii; Assanto, Giovanni; Piciocchi, Alfonso; Martelli, Maurizio; Petrucci, Maria Teresa
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study 2023 Assanto, Gm; Totaro, M; Poggiali, R; Delli Paoli, A; Annechini, G; D'Elia, Gm; Aji, F; Petrucci, L; Fazio, F; Del Giudice, I; Martelli, M; Micozzi, A; Gentile, G